KLB and obesity disorder: One working theory is that obesity-associated increases in FGF21 reflect an FGF21-resistant state due to observed downregulation of FGFR1c and KLB in the liver and WAT, as well as reduced efficacy of recombinant FGF21 (rFGF21) in mice and humans (33, 34).